These data suggest that PPARγ could be an important drug target for the chemoprevention of prostate cancer and warrant testing in prostate cancer mouse models to determine the effectiveness of targeting this pathway in a chemoprevention setting. The gene discussed is PPARG; the disease is prostate carcinoma.